logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jayesh Desai

Peter MacCallum Cancer Centre
H指数:67
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory

基于RNA的基因融合检测在肉瘤诊断和管理中的临床应用价值：澳大利亚实验室的经验

Molecular Diagnosis & Therapy
IF4.4
2025-11-110
PRE
Adel Shahnam; Catherine Mitchell; Christopher R. McEvoy; Owen W. J. Prall; Huiling Xu; Andrew P. Fellowes; David Y. Choong; Christopher M. Angel; Christine Khoo; Jia-Min Pang; Cameron Snell; Chris Van Vliet; Stephen J. Luen; Susie Bae; Anne Hamilton; Jayesh Desai; Stephen B. Fox; Jeremy Lewin
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial

YAP/TEAD抑制剂VT3989在实体瘤中的研究：一项1/2期临床试验

Nature Medicine
IF50
2025-10-190
PRE
Timothy A. Yap; David J. Kwiatkowski; Ibiayi Dagogo-Jack; Michael Offin; Marjorie G. Zauderer; Robert Kratzke; Jayesh Desai; Amy Body; Michael Millward; Anthony W. Tolcher; Kanwal P. S. Raghav; Archie Thurston; Len Post; F. Andrew Dorr; Tracy T. Tang; Yufeng Li; Neelesh Sharma; Hedy L. Kindler
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti–PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation results

一项关于OX40激动剂BGB-A445与或不与tislelizumab（一种抗PD-1单克隆抗体）联合治疗晚期实体瘤患者的I期研究：剂量递增结果

Cancer Chemotherapy and Pharmacology
IF2.3
2025-10-080
OA
Jayesh Desai; Sanjeev Deva; Bo Gao; Kunyu Yang; Kenneth J. O’Byrne; Meili Sun; Tianshu Liu; Tarek Meniawy; Xinmin Yu; Mark Voskoboynik; Diwakar Davar; Marco Matos; Shiangjiin Leaw; Tahmina Rahman; Xiaofei Qu; Hugh Giovinazzo; Xin Chen; Yan Dong; Daphne Day
Trends in Practice Patterns and Clinical Outcomes for Desmoid Tumors: A Large Single-Institutional Australian Cohort

侵袭性纤维瘤的治疗模式趋势与临床结局：一项来自澳大利亚单机构的大型队列研究

CANCER MEDICINE
IF3.1
2025-05-190
OA
Sia, Joseph; Tan, Stephanie; Mohanakrishnan, Narayan; Yu, Kelvin; Ngan, Samuel Y.; Chander, Sarat; Desai, Jayesh; Lewin, Jeremy; Hamilton, Anne; Luen, Stephen J.; Gyorki, David E.; Snow, Hayden; Dibella, Claudia; O'Reilly-Harbidge, Sarah; Orme, Lisa M.; Chu, Julie; Bae, Susie
A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study

BEACON研究中BRAF V600E突变型结直肠癌患者肿瘤分子变化的通俗性摘要

FUTURE ONCOLOGY
IF2.6
2025-05-090
OA
Kopetz, Scott; Murphy, Danielle A.; Pu, Jie; Ciardiello, Fortunato; Desai, Jayesh; Van Cutsem, Eric; Wasan, Harpreet Singh; Yoshino, Takayuki; Saffari, Hedieh; Zhang, Xiaosong; Hamilton, Phineas; Xie, Tao; Yaeger, Rona; Tabernero, Josep
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
CANCER
IF5.1
2024-11-121
OAAI
Desai, Jayesh; Wagner, Andrew J.; Carrasco Garcia, Irene; Cesari, Marilena; Gordon, Michael; Lin, Chia-Chi; Papai, Zsuzsanna; Ryan, Christopher W.; Tap, William D.; Trent, Jonathan C.; Gelderblom, Hans; Grimison, Peter; Lopez Pousa, Antonio; Van Tine, Brian A.; Rubinacci, Maria; Dai, Dong; Rajper, Abdul Waheed; Tecson, Kristen; Wooddell, Margaret; Stacchiotti, Silvia
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
NPJ PRECISION ONCOLOGY
IF8
2024-09-091
OAAI
Thavaneswaran, Subotheni; Lin, Frank; Grady, John P.; Espinoza, David; Huang, Min Li; Chinchen, Sarah; Sebastian, Lucille; Kansara, Maya; Mersiades, Tony; Lee, Chee Khoon; Desai, Jayesh; Grimison, Peter; Brown, Michael; Millward, Michael; Harrup, Rosemary; O'Byrne, Ken; Nagrial, Adnan; Craft, Paul; Simes, John; Joshua, Anthony M.; Thomas, David M.
Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplification: A molecular screening and therapeutics (MoST) program substudy

Tucatinib和Trastuzumab在HER2突变或扩增的晚期癌症中的应用：一项分子筛查与治疗（MoST）计划亚研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Kong, B. Y.; Lin, F. P-Y.; Espinoza, D.; Thavaneswaran, S.; Meniawy, T.; Desai, J.; Harrup, R.; Selva-Nayagam, S.; Charakidis, M.; Cuff, K.; Sebastian, L.; Lee, C. K.; Chinchen, S.; Thomas, D. M.; Ballinger, M. L.; Simes, J.; Goldstein, D.
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer
CELL DEATH & DISEASE
IF9.6
2024-03-010
OAAI
Jenkins, Laura J.; Luk, Ian Y.; Chionh, Fiona; Tan, Tao; Needham, Kristen; Ayton, Jamieson; Reehorst, Camilla M.; Vukelic, Natalia; Sieber, Oliver M.; Mouradov, Dmitri; Gibbs, Peter; Williams, David S.; Tebbutt, Niall C.; Desai, Jayesh; Hollande, Frederic; Dhillon, Amardeep S.; Lee, Erinna F.; Merino, Delphine; Fairlie, W. Douglas; Mariadason, John M.

研究方向

暂未获取到该数据
P
Peter Gibbs
H 指数:82论文数:1,320被引数:4.4万
O
Oliver M. Sieber
H 指数:55论文数:586被引数:1.3万
J
Josep Tabernero
H 指数:146论文数:2,711被引数:12.7万
H
Harpreet Wasan
H 指数:66论文数:431被引数:3.0万
S
Scott Kopetz
H 指数:109论文数:1,942被引数:5.8万
J
Jeanne Tie
H 指数:44论文数:447被引数:1.9万
R
Rona Yaeger
H 指数:74论文数:881被引数:3.5万
D
David M. Thomas
H 指数:76论文数:609被引数:2.4万
S
Susie Bae
H 指数:13论文数:59被引数:510
E
Eric Van Cutsem
H 指数:174论文数:1,832被引数:17.4万